More thyroid cancers were detected soon after starting a GLP-1 receptor agonist than other diabetes drugs, a secondary analysis of a target trial emulation of a comparative effectiveness study found.

NEW YORK (Reuters Health) - People with papillary thyroid cancer that hasn't spread beyond the thyroid gland appear to have good outcomes regardless of whether or not they are treated, new research ...

Thyroid cancer types include papillary, follicular, medullary, and anaplastic, each with distinct characteristics and treatment approaches. Diagnosis involves physical exams, imaging, biopsies, blood ...

MONDAY, Nov. 17, 2025 (HealthDay News) — Thyroid cancer is often a highly treatable disease. Most cases are detected in early stages and have excellent outcomes. There are several different types of ...

Phase I trial demonstrates lasting responses and encouraging safety profile in two aggressive thyroid cancer subtypes, suggesting further progress for CAR T cell therapy in solid tumors One patient ...

TAMPA, Fla., Feb. 10, 2026 /PRNewswire/ -- With the rapid rise in use of GLP-1 receptor agonist medications such as Ozempic®, Wegovy®, and Mounjaro® for diabetes and weight loss, public concern has ...

The likelihood of thyroid cancer (TC) and breast cancer (BC) occurring in the same woman are greater than would occur by chance, a new study suggests. The findings, from a retrospective case-control ...

A person can have thyroid cancer for months or years without experiencing any symptoms. Symptoms may not develop until the cancer advances. The thyroid is a gland at the base of the throat that sends ...